Q. Consider the following statements regarding Zycov-D vaccine
1. It is the world’s first and India’s indigenously developed DNA based vaccine for COVID-19.
2. The vaccine is an intradermal vaccine which means it is applied using a ‘needle-free injector’.
3. Zycov-D will be given in single dose
Which of the above statements is/are correct? 
Answer: A
Notes:
Drugs Controller General of India’s (DCGI’s) has granted emergency approval for Zycov-D vaccine.
About Zycov-D:
- Zycov-D is a DNA plasmid-based Covid-19 vaccine developed by Zycov Cadilla Group in partnership with the Department of Biotechnology under the ‘Mission COVID Suraksha’.
- It is the world’s first and India’s indigenously developed DNA based vaccine for COVID-19.
- The vaccine is an intradermal vaccine which means it is applied using a ‘needle-free injector’.
- The vaccine is to be administered in humans, including Children and adults 12 years and above.
- Unlike other Covid-19 vaccines which are given in two doses, Zycov-D will be given in three doses with an interval of 28 days between each dose.
Read more: Zydus Cadila vaccine gets emergency nod
Discover more from Free UPSC IAS Preparation Syllabus and Materials For Aspirants
Subscribe to get the latest posts sent to your email.
